Celmatix Therapeutics, a biotechnology company focused on advancing groundbreaking therapeutics for women’s health, has announced its latest drug program, a novel Jun-N-terminal kinase (JNK) inhibitor ...

The dollar strengthens as strong U.S. data drives up yields, dampening expectations of Federal Reserve rate cuts. The yen weakens near levels that previously prompted intervention, and the euro and ...